发明名称 METHYLCITRATE ANALYSIS IN DRIED BLOOD SPOTS
摘要 There is provided a method of measuring methylcitrate (MCA) in a sample by derivatizing the MCA, for example with 4-[2-(N,N-dimethylamino)ethylaminosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole (DAABD-AE); measuring a level of the derivatized MCA; and determining the level of MCA from the measured level. The sample may be a dried blood spot (DBS), and the extraction and derivatization may be carried out simultaneously. No separate extraction or purification step is required, thereby reducing sample handling. Measuring may be carried out by mass spectrometry. The method may be used to screen for subjects having or at increased risk of a propionylcarnitine (C3) related disorder. The method may be used as a first tier screen, or as a second tier test for a sample that previously triggered a positive result in a primary screen. The method may be applied to newborn screening. Related kits and uses are also provided.
申请公布号 US2016033522(A1) 申请公布日期 2016.02.04
申请号 US201514791335 申请日期 2015.07.03
申请人 Al-Dirbashi Osama;CHILDREN'S HOSPITAL OF EASTERN ONTARIO 发明人 AL-DIRBASHI Osama;CHAKRABORTY Pranesh
分类号 G01N33/64 主分类号 G01N33/64
代理机构 代理人
主权项 1. A method of measuring a level of 2-methylcitric acid (MCA) in a sample, comprising: derivatizing the MCA with 4-[2-(N,N-dimethylamino)ethylaminosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole (DAABD-AE); measuring a level of the derivatized MCA; and determining the level of MCA from the measured level of derivatized MCA.
地址 Ottawa CA
您可能感兴趣的专利